Sledovat
Robert Shafer
Robert Shafer
Professor of Medicine, Stanford University
E-mailová adresa ověřena na: stanford.edu - Domovská stránka
Název
Citace
Citace
Rok
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
A Bhimraj, RL Morgan, AH Shumaker, V Lavergne, L Baden, VCC Cheng, ...
Clinical infectious diseases 78 (7), e83-e102, 2024
14332024
2011 update of the drug resistance mutations in HIV-1
VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, R Shafer, ...
Topics in antiviral medicine 19 (4), 156, 2016
12542016
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
International HIV Controllers Study
Science 330 (6010), 1551-1557, 2010
11492010
2017 update of the drug resistance mutations in HIV-1
AM Wensing, V Calvez, HF Günthard, VA Johnson, R Paredes, D Pillay, ...
Topics in antiviral medicine 24 (4), 132, 2016
11472016
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes, H Fleury, M Kiuchi, ...
PloS one 4 (3), e4724, 2009
11392009
The biological and clinical significance of emerging SARS-CoV-2 variants
K Tao, PL Tzou, J Nouhin, RK Gupta, T de Oliveira, SL Kosakovsky Pond, ...
Nature Reviews Genetics 22 (12), 757-773, 2021
11052021
Human immunodeficiency virus reverse transcriptase and protease sequence database
SY Rhee, MJ Gonzales, R Kantor, BJ Betts, J Ravela, RW Shafer
Nucleic acids research 31 (1), 298-303, 2003
10602003
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection
PM Small, RW Shafer, PC Hopewell, SP Singh, MJ Murphy, ED Desmond, ...
New England Journal of Medicine 328 (16), 1137-1144, 1993
7801993
Web resources for HIV type 1 genotypic-resistance test interpretation
TF Liu, RW Shafer
Clinical infectious diseases 42 (11), 1608-1618, 2006
7562006
Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance
C Wang, Y Mitsuya, B Gharizadeh, M Ronaghi, RW Shafer
Genome research 17 (8), 1195-1201, 2007
5632007
HIV-1 antiretroviral resistance: scientific principles and clinical applications
MW Tang, RW Shafer
Drugs 72, e1-e25, 2012
5112012
Rationale and uses of a public HIV drug‐resistance database
RW Shafer
The Journal of infectious diseases 194 (Supplement_1), S51-S58, 2006
4802006
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection
GK Robbins, V De Gruttola, RW Shafer, LM Smeaton, SW Snyder, ...
New England Journal of Medicine 349 (24), 2293-2303, 2003
4782003
HIV-1 drug resistance mutations: an updated framework for the second decade of HAART
RW Shafer, JM Schapiro
AIDS reviews 10 (2), 67, 2008
4762008
Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection
RW Shafer, DS Kim, JP Weiss, JM Quale
Medicine 70 (6), 384-397, 1991
4701991
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
RW Shafer, SY Rhee, D Pillay, V Miller, P Sandstrom, JM Schapiro, ...
Aids 21 (2), 215-223, 2007
4422007
Genotypic testing for human immunodeficiency virus type 1 drug resistance
RW Shafer
Clinical microbiology reviews 15 (2), 247-277, 2002
4402002
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration
R Kantor, DA Katzenstein, B Efron, AP Carvalho, B Wynhoven, P Cane, ...
PLoS medicine 2 (4), e112, 2005
3922005
HIV-1 drug resistance and resistance testing
DS Clutter, MR Jordan, S Bertagnolio, RW Shafer
Infection, Genetics and Evolution 46, 292-307, 2016
3802016
Genotypic predictors of human immunodeficiency virus type 1 drug resistance
SY Rhee, J Taylor, G Wadhera, A Ben-Hur, DL Brutlag, RW Shafer
Proceedings of the National Academy of Sciences 103 (46), 17355-17360, 2006
3502006
Systém momentálně nemůže danou operaci provést. Zkuste to znovu později.
Články 1–20